Abstract
In the last years, epigenetic regulatory mechanisms are increasingly appreciated as central to a diverse array of age-associated processes such as cellular and organismal senescence, genomic instability, and tumorigenesis. Recently, histone deacetylase inhibitors (HDACIs), a novel class of drugs targeting epigenetic pathways, have been proposed as a highly promising type of drugs with anti-aging effects. This chapter presents an overview of the anti-aging and life-extending effects of HDACIs such as phenilbutyrate, sodium butyrate, trichistatin A and suberoylanilide hydroxamic acid as well as their plausible mechanism(s) of action in Drosophila melanogaster. Data supporting the hypothesis that life span extension induced by HDACIs may be caused by generalized changes in epigenetic regulation of gene expression are discussed. Overall, findings reviewed in this chapter suggest that uncovering which genetic factors and signaling pathways contributing to healthy aging can be influenced by HDACIs in fruit fly may facilitate the development of new strategies for treating and preventing age-related human diseases and health span extension.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abel T, Zukin RS (2008) Epigenetic targets of HDAC inhibition in neurodegenerative and psychiatric disorders. Curr Opin Pharmacol 8:57–64
Arking R (2009) Overview of the genomic architecture of longevity. In: Sell C, Lorenzini A, Brown-Borg HM (eds) Life Span extension: single cell organisms to man. Humana Press, Springer, Dordrecht, pp 59–73
Arking R, Novoseltseva J, Hwangbo DS et al (2002) Different age-specific demographic profiles are generated in the same normal-lived Drosophila strain by different longevity stimuli. J Gerontol A Biol Sci Med Sci 57:B390–B398
Bacalini MG, Friso S, Olivieri F et al (2014) Present and future of anti-ageing epigenetic diets. Mech Ageing Dev 136–137:101–115
Baltan S, Morrison RS, Murphy SP (2013) Novel protective effects of histone deacetylase inhibition on stroke and white matter ischemic injury. Neurotherapeutics 10:798–807
Benedetti R, Conte M, Altucci L (2014) Targeting HDACs in diseases: where are we? Antioxid Redox Signal Jan 1 (Epub ahead of print)
Berdasco M, Esteller M (2012) Hot topics in epigenetic mechanisms of aging: 2011. Aging Cell 11:181–186
Boros IM (2012) Histone modification in Drosophila. Brief Funct Genomics 11:319–331
Boumber Y, Issa JP (2011) Epigenetics in cancer: what’s the future? Oncology (Williston Park) 25(220–226):228
Boyd-Kirkup JD, Green CD, Wu G, Wang D, Han JD (2013) Epigenomics and the regulation of aging. Epigenomics 5:205–227
Buommino E, Pasquali D, Sinisi AA et al (2000) Sodium butyrate/retinoic acid costimulation induces apoptosis-independent growth arrest and cell differentiation in normal and ras-transformed seminal vesicle epithelial cells unresponsive to retinoic acid. J Mol Endocrinol 24:83–94
Chang KT, Min KT (2002) Regulation of lifespan by histone deacetylase. Ageing Res Rev 1:313–326
Chen T, Sun H, Lu J et al (2002) Histone acetylation is involved in hsp70 gene transcription regulation in Drosophila melanogaster. Arch Biochem Biophys 408:171–176
Cho Y, Griswold A, Campbell C et al (2005) Individual histone deacetylases in Drosophila modulate transcription of distinct genes. Genomics 86:606–617
Davie JR, Spencer VA (1999) Control of histone modifications. J Cell Biochem Suppl 32–33:141–148
Dominguez LJ, Barbagallo M, Morley JE (2009) Anti-aging medicine: pitfalls and hopes. Aging Male 12:13–20
Doroszuk A, Jonker MJ, Pul N et al (2012) Transcriptome analysis of a long-lived natural Drosophila variant: a prominent role of stress- and reproduction-genes in lifespan extension. BMC Genomics 13:167
Gao L, Cueto MA, Asselbergs F et al (2002) Cloning and functional characterization of HDAC11, a novel member of the human histone deacetylase family. J Biol Chem 277:25748–25755
Hahnen E, Hauke J, Tränkle C et al (2008) Histone deacetylase inhibitors: possible implications for neurodegenerative disorders. Expert Opin Investig Drugs 17:169–184
Helfand SL, Rogina B (2003) Molecular genetics of aging in the fly: is this the end of the beginning? BioEssays 25:134–141
Huidobro C, Fernandez AF, Fraga MF (2013) Aging epigenetics: causes and consequences. Mol Aspects Med 34:765–781
Iannitti T, Palmieri B (2011) Clinical and experimental applications of sodium phenylbutyrate. Drugs R D 11:227–249
Imai S, Armstrong CM, Kaeberlein M et al (2000) The transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature 403:795–800
Issa JP (1999) Aging, DNA methylation and cancer. Crit Rev Oncol Hematol 32:31–43
Johnstone RW (2002) Histone-deacetylase inhibitors: novel drugs for the treatment of cancer. Nat Rev Drug Discov 1:287–299
Jylhava J (2014) Determinants of longevity: genetics, biomarkers and therapeutic approaches. Curr Pharm Des 20(38):6058–6070
Kang H-L, Benzer S, Min K-T (2002) Life extension in Drosophila by feeding a drug. Proc Natl Acad Sci USA 99:838–843
Kapoor VK, Dureja J, Chadha R (2009) Synthetic drugs with anti-ageing effects. Drug Discov Today 14:899–904
Khan S, Jena GB (2014) Protective role of sodium butyrate, a HDAC inhibitor on beta-cell proliferation, function and glucose homeostasis through modulation of p38/ERK MAPK and apoptotic pathways: study in juvenile diabetic rat. Chem Biol Interact 213:1–12
Kouzarides T (2007) Chromatin modifications and their function. Cell 128:693–705
Kuo MH, Allis CD (1998) Roles of histone acetyltransferases and deacetylases in gene regulation. Bioessays 20:615–626
Larson K, Yan S-J, Tsurumi A et al (2012) Heterochromatin formation promotes longevity and represses ribosomal RNA synthesis. PLoS Genet 8:e1002473
Licciardi PV, Ververis K, Tang ML et al (2013) Immunomodulatory effects of histone deacetylase inhibitors. Curr Mol Med 13:640–647
Lucanic M, Lithgow GJ, Alavez S (2013) Pharmacological lifespan extension of invertebrates. Ageing Res Rev 12:445–458
Lyko F, Beisel C, Marhold J et al (2006) Epigenetic regulation in Drosophila. Curr Top Microbiol Immunol 310:23–44
McDonald P, Maizi BM, Arking R (2013) Chemical regulation of mid- and late-life longevities in Drosophila. Exp Gerontol 48:240–249
Morris BJ (2013) Seven sirtuins for seven deadly diseases of aging. Free Radic Biol Med 56:133–171
Muñoz-Najar U, Sedivy JM (2011) Epigenetic control of aging. Antioxid Redox Signal 14:241–259
Orr WC, Sohal RS (1994) Extension of lifespan by overexpression of superoxide dismutase and catalase in Drosophila melanogaster. Science 263:1128–1130
Pile LA, Lee FW, Wassarman DA (2001) The histone deacetylase inhibitor trichostatin A influences the development of Drosophila melanogaster. Cell Mol Life Sci 11:1715–1718
Rando TA, Chang HY (2012) Aging, rejuvenation, and epigenetic reprogramming: resetting the aging clock. Cell 148:46–57
Ridgel AL, Ritzmann RE (2005) Insights into age-related locomotor declines from studies of insects. Ageing Res Rev 4:23–39
Satoh A, Stein L, Imai S (2011) The role of mammalian sirtuins in the regulation of metabolism, aging, and longevity. Handb Exp Pharmacol 206:125–162
Seroude L, Brummel T, Kapahi P et al (2002) Spatio-temporal analysis of gene expression during aging in Drosophila melanogaster. Aging Cell 1:47–56
Sinclair DA, Guarente L (2014) Small-molecule allosteric activators of sirtuins. Annu Rev Pharmacol Toxicol 54:363–380
Slingerland M, Guchelaar HJ, Gelderblom H (2014) Histone deacetylase inhibitors: an overview of the clinical studies in solid tumors. Anticancer Drugs 25:140–149
St Laurent R, O’Brien LM, Ahmad ST (2013) Sodium butyrate improves locomotor impairment and early mortality in a rotenone-induced Drosophila model of Parkinson’s disease. Neuroscience 246:382–390
Steffan JS, Bodai L, Pallos J et al (2001) Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila. Nature 413:739–743
Sun X, Komatsu T, Lim J et al (2012) Nutrient-dependent requirement for SOD1 in lifespan extension by protein restriction in Drosophila melanogaster. Aging Cell 11:783–793
Swaminathan A, Gajan A, Pile LA (2012) Epigenetic regulation of transcription in Drosophila. Front Biosci 17:909–937
Symonenko AV, Roshina NV, Kolyada AK et al (2014) Changes in Drosophila melanogaster lifespan and gene expression profiling caused by the histone deacetylase inhibitors. In: Abstracts of the 3rd international conference “genetics of aging and longevity”, Moscow, Russia, April 2014
Tao D, Lu J, Sun H et al (2004) Trichostatin A extends the lifespan of Drosophila melanogaster by elevating hsp22 expression. Acta Biochim Biophys Sinica 36:618–622
Tatar M, Khazaeli AA, Curtsinger JW (1997) Chaperoning extended life. Nature 390:30
Toba G, Aigaki T (2000) Disruption of the microsomal glutathione S-transferase-like gene reduces life span of Drosophila melanogaster. Gene 253:179–187
Tollefsbol TO (2014) Dietary epigenetics in cancer and aging. Cancer Treat Res 159:257–267
Uchiumi F, Oyama T, Ozaki K (2012) A new protocol to discover novel anti-aging compounds. Pharmaceut Anal Acta 3:7. doi:10.4172/2153-2435.1000166
Vaiserman AM (2008) Epigenetic engineering and its possible role in anti-aging intervention. Rejuvenation Res 11:39–42
Vaiserman A (2011) Hormesis and epigenetics: is there a link? Ageing Res Rev 10:413–421
Vaiserman AM, Pasyukova EG (2012) Epigenetic drugs: a novel anti-aging strategy? Front Genet 3:224
Vaiserman AM, Koliada AK, Koshel NM et al (2012) Effect of the histone deacetylase inhibitor sodium butyrate on the viability and life span in Drosophila melanogaster. Adv Gerontol 25:126–131 [In Russian]
Vaiserman AM, Koshel NM, Zabuga OG et al (2013) Determination of geroprotective potential of sodium butyrate in Drosophila melanogaster: long-term effects. Adv Gerontol 26:111–116 [In Russian]
Vanhaecke T, Papeleu P, Elaut G et al (2004) Trichostatin A-like hydroxamate histone deacetylase inhibitors as therapeutic agents: toxicological point of view. Curr Med Chem 11:1629–1643
Villeponteau B (1997) The heterochromatin loss model of aging. Exp Gerontol 32:383–394
Webster GC, Webster SL (1984) Specific disappearance of translatable messenger RNA for elongation factor one in aging Drosophila melanogaster. Mech Aging Dev 24:335–342
West AC, Johnstone RW (2014) New and emerging HDAC inhibitors for cancer treatment. J Clin Invest 124:30–39
Witt O, Deubzer HE, Milde T et al (2009) HDAC family: what are the cancer relevant targets? Cancer Lett 277:8–21
Wood JG, Helfand SL (2013) Chromatin structure and transposable elements in organismal aging. Front Genet 4:274
Wood JG, Hillenmeyer S, Lawrence C et al (2010) Chromatin remodeling in the aging genome of Drosophila. Aging Cell 9:971–978
Yin D, Ong JM, Hu J et al (2007) Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor: effects on gene expression and growth of glioma cells in vitro and in vivo. Clin Cancer Res 3:1045–1052
Yuan H, Su L, Chen WY (2013) The emerging and diverse roles of sirtuins in cancer: a clinical perspective. Onco Targets Ther 6:1399–1416
Zentner GE, Henikoff S (2013) Regulation of nucleosome dynamics by histone modifications. Nat Struct Mol Biol 3:259–266
Zhao Y, Lu J, Sun H et al (2005a) Histone acetylation regulates both transcription initiation and elongation of hsp22 gene in Drosophila. Biochem Biophys Res Commun 326:811–816
Zhao Y, Sun H, Lu J et al (2005b) Lifespan extension and elevated hsp gene expression in Drosophila caused by histone deacetylase inhibitors. J Exp Biol 208(Pt 4):697–705
Zhao YM, Chen X, Sun H et al (2006) Effects of histone deacetylase inhibitors on transcriptional regulation of the hsp70 gene in Drosophila. Cell Res 16:566–576
Zhao Y, Lu J, Sun H et al (2007) Roles of histone acetylation modification in basal and inducible expression of hsp26 gene in D. melanogaster. Mol Cell Biochem 306:1–8
Zhou Q, Dalgard CL, Wynder C et al (2011) Histone deacetylase inhibitors SAHA and sodium butyrate block G1-to-S cell cycle progression in neurosphere formation by adult subventricular cells. BMC Neurosci 12:50. doi:10.1186/1471-2202-12-50
Acknowledgments
The authors would like to thank Oksana Zabuga for the assistance in preparing the manuscript. This work was supported by a joint grant of the Russian Foundation for Basic Research and the State Fund for Fundamental Research of Ukraine (project no. 11-04-90478-Ukr_f_a).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Vaiserman, A.M., Pasyukova, E.G. (2015). Life Extension in Drosophila by Histone Deacetylase Inhibitors. In: Vaiserman, A., Moskalev, A., Pasyukova, E. (eds) Life Extension. Healthy Ageing and Longevity, vol 3. Springer, Cham. https://doi.org/10.1007/978-3-319-18326-8_11
Download citation
DOI: https://doi.org/10.1007/978-3-319-18326-8_11
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-18325-1
Online ISBN: 978-3-319-18326-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)